EJP RD - EJP RD - JTC 2020 - Pre-clinical research to develop effective therapies for rare diseases

Genetic therapy for EYS- and USH2A-associated retinal disease – GET-READY

Project coordination

Rob COLLIN (STICHTING KATHOLIEKE UNIVERSITEIT NIJMEGEN)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

UNIVERSITEIT GENT
STICHTING KATHOLIEKE UNIVERSITEIT NIJMEGEN
INM Institut des Neurosciences de Montpellier - Déficits Sensoriels et Moteurs
VILNIUS UNIVERSITY
JUSTUS-LIEBIG-UNIVERSITY GIESSEN
FONDAZIONE TELETHON

Help of the ANR 475,000 euros
Beginning and duration of the scientific project: May 2021 - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter